PDL Biopharma of Incline Village reported last week that it earned $45.9 million in the third quarter, which compares with earnings of $40.2 million in the comparable quarter last year.
The company owns a portfolio of patent and royalty interests.
Comments
Use the comment form below to begin a discussion about this content.
Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment